UK markets closed

Oncopeptides AB (publ) (0RN4.IL)

IOB - IOB Delayed price. Currency in SEK
Add to watchlist
3.00500.0000 (0.00%)
At close: 06:00PM BST
Full screen
Previous close3.0050
Open0.0000
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range2.9558 - 2.9558
52-week range2.8900 - 11.2150
Volume1,245,590
Avg. volume9,231
Market cap308.184M
Beta (5Y monthly)-0.66
PE ratio (TTM)N/A
EPS (TTM)-3.3900
Earnings date03 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa

    DUBAI, United Arab Emirates and STOCKHOLM, Sweden, March 27, 2024 (GLOBE NEWSWIRE) -- Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Vector Pharma FZCO (“Vector”) today announced a collaboration to commercialize Oncopeptides’ flagship drug Pepaxti (melphalan flufenamide) in the Middle East and North Africa (“MENA”) countries of Saudi Arabia, Qatar, UAE, Bahrain, Kuwait, Oman, Algeria, Tunisia, Morocco, Libya, Lebanon, and Iraq. Under the terms of this e